Literature DB >> 29369751

Extent of BOLD Vascular Dysregulation Is Greater in Diffuse Gliomas without Isocitrate Dehydrogenase 1 R132H Mutation.

Zachary K Englander1, Craig I Horenstein1, Stephen G Bowden1, Daniel S Chow1, Marc L Otten1, Angela Lignelli1, Jeffrey N Bruce1, Peter Canoll1, Jack Grinband1.   

Abstract

Purpose To determine the effect that R132H mutation status of diffuse glioma has on extent of vascular dysregulation and extent of residual blood oxygen level-dependent (BOLD) abnormality after surgical resection. Materials and Methods This study was an institutional review board-approved retrospective analysis of an institutional database of patients, and informed consent was waived. From 2010 to 2017, 39 treatment-naïve patients with diffuse glioma underwent preoperative echo-planar imaging and BOLD functional magnetic resonance imaging. BOLD vascular dysregulation maps were made by identifying voxels with time series similar to tumor and dissimilar to healthy brain. The spatial overlap between tumor and vascular dysregulation was characterized by using the Dice coefficient, and areas of BOLD abnormality outside the tumor margins were quantified as BOLD-only fraction (BOF). Linear regression was used to assess effects of R132H status on the Dice coefficient, BOF, and residual BOLD abnormality after surgical resection. Results When compared with R132H wild-type (R132H-) gliomas, R132H-mutated (R132H+) gliomas showed greater spatial overlap between BOLD abnormality and tumor (mean Dice coefficient, 0.659 ± 0.02 [standard error] for R132H+ and 0.327 ± 0.04 for R132H-; P < .001), less BOLD abnormality beyond the tumor margin (mean BOF, 0.255 ± 0.03 for R132H+ and 0.728 ± 0.04 for R132H-; P < .001), and less postoperative BOLD abnormality (residual fraction, 0.046 ± 0.0047 for R132H+ and 0.397 ± 0.045 for R132H-; P < .001). Receiver operating characteristic curve analysis showed high sensitivity and specificity in the discrimination of R132H+ tumors from R132H- tumors with calculation of both Dice coefficient and BOF (area under the receiver operating characteristic curve, 0.967 and 0.977, respectively). Conclusion R132H mutation status is an important variable affecting the extent of tumor-associated vascular dysregulation and the residual vascular dysregulation after surgical resection. © RSNA, 2018 Online supplemental material is available for this article.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29369751     DOI: 10.1148/radiol.2017170790

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  RP-Rs-fMRIomics as a Novel Imaging Analysis Strategy to Empower Diagnosis of Brain Gliomas.

Authors:  Xiaoxue Liu; Jianrui Li; Qiang Xu; Qirui Zhang; Xian Zhou; Hao Pan; Nan Wu; Guangming Lu; Zhiqiang Zhang
Journal:  Cancers (Basel)       Date:  2022-06-07       Impact factor: 6.575

2.  Static 18F-FET PET and DSC-PWI based on hybrid PET/MR for the prediction of gliomas defined by IDH and 1p/19q status.

Authors:  Shuangshuang Song; Leiming Wang; Hongwei Yang; Yongzhi Shan; Ye Cheng; Lixin Xu; Chengyan Dong; Guoguang Zhao; Jie Lu
Journal:  Eur Radiol       Date:  2020-11-19       Impact factor: 5.315

3.  Feasibility of glioblastoma tissue response mapping with physiologic BOLD imaging using precise oxygen and carbon dioxide challenge.

Authors:  Vittorio Stumpo; Martina Sebök; Christiaan Hendrik Bas van Niftrik; Katharina Seystahl; Nicolin Hainc; Zsolt Kulcsar; Michael Weller; Luca Regli; Jorn Fierstra
Journal:  MAGMA       Date:  2021-12-07       Impact factor: 2.310

4.  BOLD asynchrony: An imaging biomarker of tumor burden in IDH-mutated gliomas.

Authors:  Behroze Adi Vachha; Raymond Y Huang
Journal:  Neuro Oncol       Date:  2022-01-05       Impact factor: 12.300

5.  Simultaneous FET-PET and contrast-enhanced MRI based on hybrid PET/MR improves delineation of tumor spatial biodistribution in gliomas: a biopsy validation study.

Authors:  Shuangshuang Song; Ye Cheng; Jie Ma; Leiming Wang; Chengyan Dong; Yukui Wei; Geng Xu; Yang An; Zhigang Qi; Qingtang Lin; Jie Lu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-01-09       Impact factor: 9.236

Review 6.  Advancements in Neuroimaging to Unravel Biological and Molecular Features of Brain Tumors.

Authors:  Francesco Sanvito; Antonella Castellano; Andrea Falini
Journal:  Cancers (Basel)       Date:  2021-01-23       Impact factor: 6.639

7.  Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study.

Authors:  Michele Bailo; Nicolò Pecco; Marcella Callea; Paola Scifo; Filippo Gagliardi; Luca Presotto; Valentino Bettinardi; Federico Fallanca; Paola Mapelli; Luigi Gianolli; Claudio Doglioni; Nicoletta Anzalone; Maria Picchio; Pietro Mortini; Andrea Falini; Antonella Castellano
Journal:  Front Neurosci       Date:  2022-07-13       Impact factor: 5.152

8.  BOLD asynchrony elucidates tumor burden in IDH-mutated gliomas.

Authors:  Petros D Petridis; Craig I Horenstein; Brianna Pereira; Peter B Wu; Jorge Samanamud; Tamara Marie; Deborah Boyett; Tejaswi D Sudhakar; Sameer A Sheth; Guy M McKhann; Michael B Sisti; Jeffrey N Bruce; Peter Canoll; Jack Grinband
Journal:  Neuro Oncol       Date:  2022-01-05       Impact factor: 13.029

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.